Comparative evaluation of NESTROFT and RDW as screening tests for beta thalassemia trait in pregnancy

Pritibala Patel, Nivedita Sarda, Renu Arora, Harsha Shailesh Gaikwad

Abstract


Background: Thalassemia is the commonest inherited hemoglobinopathy. It is estimated that there are about 45 million carriers of the beta thalassemia gene and about 15000 affected infants are born every year in India, thereby contributing to about 10% of the total thalassemia babies born all over the world. Beta Thalassemia Trait (BTT) is asymptomatic while Beta Thalassemia Major (BTM) presents with severe anemia and requires lifelong blood transfusion, so emphasis must shift from treatment to screening and offering prenatal counseling to affected parents.

Methods: It was a hospital based cross sectional study on 500 antenatal women with microcytic hypochromic anemia with hemoglobin <9 gm% and MCV <80 fl and all these women underwent Naked Eye Single Tube Red Cell Osmotic Fragility Test (NESTROFT), High Performance Liquid Chromatography (HPLC) and serum ferritin estimation.

Results: In our study the sensitivity and specificity of NESTROFT was 93.3% and 95.7% respectively compared to Red cell Distribution Width (RDW) with a sensitivity and specificity of 66.6% and 78.9% respectively.

Conclusions: For low resource settings like India, screening for beta thalassemia by NESTROFT is a cheaper and more reliable method with a high sensitivity and specificity and can be performed easily by paramedical staff.

Keywords


NESTROFT, Microcytosis, Thalassemia

Full Text:

PDF

References


Balgir RS. Control and prevention of the genetic load of haemoglobinopathies in India. Natl Med J India. 1999;12:234-8.

Indian Council of Medical Research. Collaborative study on thalassemia. In: ICMR, eds. ICMR Task Force Study. New Delhi: Indian Council of Medical Research; 1993.

Balgir RS. The burden of haemoglobinopathies in India and the challenges ahead. Curr Sci. 2000;79:1536-7.

Choudhry VP, Desai N, Pati HP. Current management of homozygous beta-thalassemia. Indian Pediatr. 1991;28:1221-9.

Flynn MM, Reppun TS, Bhagavan NV. Limitations of red blood cell distribution width (RDW) in evaluation of microcytosis. Am J Clin Pathol. 1986;85(4):445-9.

Mehta BC, Gandhi S, Mehta JB. Naked eye single tube red cell osmotic fragility test for beta-thalassemia: population survey. Indian J Haematol. 1988;6:187-90.

Afshan Sumera, Sulaiman Ahmed, S. M. Adnan Ali, Rafiq Khanani. Evaluation of NESTROFT as a marker of differentiation between β-thalassemia trait & iron deficiency anemia. Int J Collab Res Intern Med Public Health. 2012;4:1560-6.

Indranil Chakrabarti, Swapan Kumar Sinha, Nilanjana Ghosh, Bidyut Krishna Goswami. Beta-thalassemia carrier detection by NESTROFT: an answer in rural scenario? Iran J Pathol. 2012;7(1):19-26.

Vijay Bharat, Subash Gupta, Rachna Gupta. Detection of carriers for β-thalassemia: a case study of Jammu (J&K). Orient J Chem. 2010;26(1):199-206.

Singh SP, Gupta SC. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta thalassemia trait. Singapore Med J. 2008;49(10):823-6.

Thompson WG, Meola T, Lipkin M Jr, Freedman ML. Red cell distribution width, mean corpuscular volume and transferrin saturation in diagnosis of IDA. Arch Intern Med. 1988;148:2128-30.

Van Zeben D, Bieger R, Van Wermeskerken RK, Castel A, Hermans J. Evaluation of microcytosis using serum ferritin and red blood cell distribution width. Eur J Haematol. 1990;54:106-9.